TETRAPHASE PHARMACEUTICALS INC (38)

Browse by Contract Category

Contracts

Form of Exchange Agreement, dated June 24, 2020, by and among the Parent, the Purchaser and the holder named therein (Filed With SEC on June 24, 2020)
Form of Support Agreement, dated June 24, 2020, by and among the Parent, the Purchaser and the stockholder named therein (Filed With SEC on June 24, 2020)
Agreement and Plan of Merger by and among the Parent, the Purchaser and the Company, dated June 24, 2020 (Filed With SEC on June 24, 2020)
Amendment, dated January 31, 2020, to Lease Agreement, dated as of November 16, 2006, by and between the Registrant and ARE-480 Arsenal Street, LLC, as amended (Filed With SEC on March 12, 2020)
Amendment No.1, dated July 29, 2019, to the License Agreement between Everest Medicines Limited and the Registrant (Filed With SEC on August 8, 2019)
Consulting agreement, dated as of July 31, 2019, by and between the Registrant and Guy Macdonald (Filed With SEC on August 8, 2019)
Form of Contingent Value Rights Agreement, by and between the Parent and the Rights Agent (Filed With SEC on June 24, 2020)
Agreement and Plan of Merger by and among the Parent, the Purchaser and the Company, dated June 4, 2020 (Filed With SEC on June 4, 2020)
Form of Exchange Agreement, dated June 4, 2020, by and among the Parent, the Purchaser and the holder named therein (Filed With SEC on June 4, 2020)
Form of Support Agreement, dated June 4, 2020, by and among the Parent, the Purchaser and the stockholder named therein (Filed With SEC on June 4, 2020)
Form of Contingent Value Rights Agreement, by and between the Parent and the Rights Agent (Filed With SEC on June 4, 2020)
Second Amendment to Agreement and Plan of Merger, by and among Parent, Merger Sub and Company, dated May 29, 2020 (Filed With SEC on May 29, 2020)
Form of Contingent Value Rights Agreement, by and between AcelRx and the Rights Agent (Filed With SEC on May 29, 2020)
Form of Contingent Value Rights Agreement, by and between AcelRx and the Rights Agent (Filed With SEC on May 27, 2020)
Amendment to Agreement and Plan of Merger, by and among Parent, Merger Sub and Company, dated May 26, 2020 (Filed With SEC on May 27, 2020)
Promissory Note, dated April 22, 2020, by and between Tetraphase Pharmaceuticals, Inc. and Silicon Valley Bank, N.A (Filed With SEC on April 28, 2020)
Form of Contingent Value Rights Agreement, by and between the Parent and the Rights Agent (Filed With SEC on March 16, 2020)
Agreement and Plan of Merger by and among Parent, Merger Sub and Company, dated March 15, 2020 (Filed With SEC on March 16, 2020)
Form of Exchange Agreement, dated March 15, 2020, by and among the Parent, Merger Sub and the holder named therein (Filed With SEC on March 16, 2020)
Form of Voting Agreement, dated March 15, 2020, by and among the Parent, Merger Sub and the stockholder named therein (Filed With SEC on March 16, 2020)
Co-Promotion Agreement, dated March 15, 2020, by and between the Parent and the Company (Filed With SEC on March 16, 2020)
Description of Registrants Securities (Filed With SEC on March 12, 2020)
Form of RD Securities Purchase Agreement, dated January 22, 2020, by and among the Company and the other persons party thereto (Filed With SEC on January 23, 2020)
Form of PIPE Securities Purchase Agreement, dated January 22, 2020, by and among the Company and the other persons party thereto (Filed With SEC on January 23, 2020)
Form of Registered Common Warrant (Filed With SEC on January 23, 2020)
Form of Registered Pre-Funded Warrant (Filed With SEC on January 23, 2020)
Form of Unregistered Common Warrant (Filed With SEC on January 23, 2020)
Form of Unregistered Pre-Funded Warrant (Filed With SEC on January 23, 2020)
Form of Registration Rights Agreement, dated January 22, 2020, by and among the Company and the other persons party thereto (Filed With SEC on January 23, 2020)
Form of Common Stock Warrant (Filed With SEC on October 30, 2019)
Form of Securities Purchase Agreement, dated October 29, 2019, between the Company and the Purchaser (Filed With SEC on October 30, 2019)
Form of Pre-Funded Warrant (Filed With SEC on October 30, 2019)
Payoff Letter, entered into as of August 30, 2019, by and among Tetraphase Pharmaceuticals, Inc., Solar Capital Ltd., as collateral agent and lender, and the other lenders named... (Filed With SEC on August 30, 2019)
Separation agreement, dated as of July 31, 2019, by and between the Registrant and Guy Macdonald (Filed With SEC on August 8, 2019)
Offer letter, dated as of July 31, 2019, by and between the Registrant and Larry Edwards (Filed With SEC on August 8, 2019)
Amendment No. 1 to Tetraphase Pharmaceuticals, Inc. 2014 Employee Stock Purchase Plan, dated March 13, 2019 (Filed With SEC on May 8, 2019)
First Amendment to Loan and Security Agreement, dated as of March 14, 2019, by and between the registrant and Solar Capital Ltd., in its capacity as collateral agent (Filed With SEC on May 8, 2019)
Amendment, dated November 29, 2018, to Lease Agreement, dated as of November 16, 2006, by and between the Registrant and ARE-480 Arsenal Street, LLC, as amended (Filed With SEC on March 15, 2019)